279 related articles for article (PubMed ID: 24559284)
1. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.
Hunter Z; McCarthy DP; Yap WT; Harp CT; Getts DR; Shea LD; Miller SD
ACS Nano; 2014 Mar; 8(3):2148-60. PubMed ID: 24559284
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle dose and antigen loading attenuate antigen-specific T-cell responses.
Casey LM; Decker JT; Podojil JR; Rad L; Hughes KR; Rose JA; Pearson RM; Miller SD; Shea LD
Biotechnol Bioeng; 2023 Jan; 120(1):284-296. PubMed ID: 36221192
[TBL] [Abstract][Full Text] [Related]
3. Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance.
Kuo R; Saito E; Miller SD; Shea LD
Mol Ther; 2017 Jul; 25(7):1676-1685. PubMed ID: 28408181
[TBL] [Abstract][Full Text] [Related]
4. An antigen-encapsulating nanoparticle platform for T
McCarthy DP; Yap JW; Harp CT; Song WK; Chen J; Pearson RM; Miller SD; Shea LD
Nanomedicine; 2017 Jan; 13(1):191-200. PubMed ID: 27720992
[TBL] [Abstract][Full Text] [Related]
5. Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.
Verbeke CS; Gordo S; Schubert DA; Lewin SA; Desai RM; Dobbins J; Wucherpfennig KW; Mooney DJ
Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28116870
[TBL] [Abstract][Full Text] [Related]
6. ROS-Scavenging Lignin-Based Tolerogenic Nanoparticle Vaccine for Treatment of Multiple Sclerosis.
Phan NM; Nguyen TL; Shin H; Trinh TA; Kim J
ACS Nano; 2023 Dec; 17(24):24696-24709. PubMed ID: 38051295
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis.
Au KM; Tisch R; Wang AZ
Adv Mater; 2022 Feb; 34(5):e2107392. PubMed ID: 34775659
[TBL] [Abstract][Full Text] [Related]
8. Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides.
Pfeil J; Simonetti M; Lauer U; von Thülen B; Durek P; Poulsen C; Pawlowska J; Kröger M; Krähmer R; Leenders F; Hoffmann U; Hamann A
Ther Adv Chronic Dis; 2021; 12():20406223211037830. PubMed ID: 34408824
[TBL] [Abstract][Full Text] [Related]
9. Administration of ROS-Scavenging Cerium Oxide Nanoparticles Simply Mixed with Autoantigenic Peptides Induce Antigen-Specific Immune Tolerance against Autoimmune Encephalomyelitis.
Nguyen TL; Phan NM; Kim J
ACS Appl Mater Interfaces; 2024 Jun; ():. PubMed ID: 38906850
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials for antigen-specific immune tolerance therapy.
Park J; Wu Y; Li Q; Choi J; Ju H; Cai Y; Lee J; Oh YK
Drug Deliv Transl Res; 2023 Jul; 13(7):1859-1881. PubMed ID: 36094655
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Surgical Brain Injury by Immune Tolerance Induced by Peripheral Intravenous Injection of Biotargeting Nanoparticles Loaded With Brain Antigens.
Tian Z; Xu L; Chen Q; Feng R; Lu H; Tan H; Kang J; Wang Y; Yan H
Front Immunol; 2019; 10():743. PubMed ID: 31024567
[TBL] [Abstract][Full Text] [Related]
12. Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Tremain AC; Wallace RP; Lorentz KM; Thornley TB; Antane JT; Raczy MR; Reda JW; Alpar AT; Slezak AJ; Watkins EA; Maulloo CD; Budina E; Solanki A; Nguyen M; Bischoff DJ; Harrington JL; Mishra R; Conley GP; Marlin R; Dereuddre-Bosquet N; Gallouët AS; LeGrand R; Wilson DS; Kontos S; Hubbell JA
Nat Biomed Eng; 2023 Sep; 7(9):1142-1155. PubMed ID: 37679570
[TBL] [Abstract][Full Text] [Related]
13. Cationic nanoparticles-based approaches for immune tolerance induction in vivo.
Mao K; Wang J; Xie Q; Yang YG; Shen S; Sun T; Wang J
J Control Release; 2024 Feb; 366():425-447. PubMed ID: 38154540
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles and direct immunosuppression.
Ngobili TA; Daniele MA
Exp Biol Med (Maywood); 2016 May; 241(10):1064-73. PubMed ID: 27229901
[TBL] [Abstract][Full Text] [Related]
15. Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
Huq R; Samuel EL; Sikkema WK; Nilewski LG; Lee T; Tanner MR; Khan FS; Porter PC; Tajhya RB; Patel RS; Inoue T; Pautler RG; Corry DB; Tour JM; Beeton C
Sci Rep; 2016 Sep; 6():33808. PubMed ID: 27654170
[TBL] [Abstract][Full Text] [Related]
16. Tolerance-inducing medicines in autoimmunity: rheumatology and beyond.
Stanway JA; Isaacs JD
Lancet Rheumatol; 2020 Sep; 2(9):e565-e575. PubMed ID: 38273619
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles targeting monocytes and macrophages as diagnostic and therapeutic tools for autoimmune diseases.
Álvarez K; Rojas M
Heliyon; 2023 Sep; 9(9):e19861. PubMed ID: 37810138
[TBL] [Abstract][Full Text] [Related]
18. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Maldonado RA; LaMothe RA; Ferrari JD; Zhang AH; Rossi RJ; Kolte PN; Griset AP; O'Neil C; Altreuter DH; Browning E; Johnston L; Farokhzad OC; Langer R; Scott DW; von Andrian UH; Kishimoto TK
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E156-65. PubMed ID: 25548186
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization.
Smarr CB; Yap WT; Neef TP; Pearson RM; Hunter ZN; Ifergan I; Getts DR; Bryce PJ; Shea LD; Miller SD
Proc Natl Acad Sci U S A; 2016 May; 113(18):5059-64. PubMed ID: 27091976
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation.
Bryant J; Hlavaty KA; Zhang X; Yap WT; Zhang L; Shea LD; Luo X
Biomaterials; 2014 Oct; 35(31):8887-8894. PubMed ID: 25066477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
